Literature DB >> 25182754

23-hour/next day discharge post-laparoscopic Roux-en-Y gastric bypass (LRYGB) surgery is safe.

S Waydia1, A Gunawardene, J Gilbert, A Cota, I G Finlay.   

Abstract

Laparoscopic Roux-en-Y gastric bypass (LRYGB) is well established, yet practice varies as to when patients should be discharged post operation. After noting that many LRYGB patients met our unit's discharge criteria sooner than anticipated, we implemented a policy of aiming for 23-h inpatient stay post LRYGB in January 2012. This retrospective study aimed to assess the safety of this policy. We reviewed data of all patients undergoing LRYGB at our unit from September 2010 to October 2013. We compared the lengths of inpatient stay, complication rates and re-admission rates of patients treated before and after the introduction of the 23-h length of stay policy. Of 161 LRYGB procedures, 38 patients (29 female) underwent LRYGB from September 2010 to December 2011 (pre-policy change) and 123 (107 female) underwent operation after this date (post-policy change). The two groups were similar in terms of mean age (46.5 vs. 46.7 years, p = 0.932), mean BMI (46.8 vs. 46.6 kg/m(2), p = 0.868) and median number of pre-operative comorbidities (3 vs. 3, p = 0.9). There were significant reductions in median length of inpatient stay (2 vs. 1 day, p < 0.0001), re-admission rate (21.1 to 6.5 %, p = 0.025) and complication rate (18.4 vs. 3.3 %, p = 0.004) after the policy change. There were seven complications pre-policy change: pulmonary embolus (n = 1), chest infection (n = 1), constipation and anal fissure (n = 1), umbilical hernia requiring operation (n = 2), adhesional obstruction (n = 1) and persistent food intolerance (n = 1). Post-policy changes, there were four complications: adhesional obstruction (n = 2), staple line bleeding (n = 1) and persistent dysphagia (n = 1). There were no deaths. Patients undergoing LRYGB can be safely discharged on the first post-operative day. This reduction in length of inpatient stay offers significant cost savings.

Entities:  

Mesh:

Year:  2014        PMID: 25182754     DOI: 10.1007/s11695-014-1409-5

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  7 in total

1.  High-volume bariatric surgery in a single center: safety, quality, cost-efficacy and teaching aspects in 2,000 consecutive cases.

Authors:  H J Jacobsen; A Bergland; J Raeder; H G Gislason
Journal:  Obes Surg       Date:  2012-01       Impact factor: 4.129

2.  Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients.

Authors:  K D Higa; K B Boone; T Ho; O G Davies
Journal:  Arch Surg       Date:  2000-09

3.  Length of stay and impact on readmission rates after laparoscopic gastric bypass.

Authors:  Matthew T Baker; Michael D Lara; Christopher J Larson; Pamela J Lambert; Michelle A Mathiason; Shanu N Kothari
Journal:  Surg Obes Relat Dis       Date:  2006 Jul-Aug       Impact factor: 4.734

Review 4.  Systematic review of 23-hour (outpatient) stay laparoscopic gastric bypass surgery.

Authors:  Harun Thomas; Sanjay Agrawal
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2011-07-21       Impact factor: 1.878

5.  Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence, treatment and prevention.

Authors:  Kelvin D Higa; Tienchin Ho; Keith B Boone
Journal:  Obes Surg       Date:  2003-06       Impact factor: 4.129

Review 6.  Fast-track laparoscopic bariatric surgery: a systematic review.

Authors:  Jessie A Elliott; Vanash M Patel; Ali Kirresh; Hutan Ashrafian; Carel W Le Roux; Torsten Olbers; Thanos Athanasiou; Emmanouil Zacharakis
Journal:  Updates Surg       Date:  2013-02-01

7.  23-hour stay outcomes for laparoscopic Roux-en-Y gastric bypass in a small, teaching community hospital.

Authors:  Louis G Fares; Rachel C Reeder; John Bock; Valerie Batezel
Journal:  Am Surg       Date:  2008-12       Impact factor: 0.688

  7 in total
  7 in total

1.  Same-Day Discharge after Laparoscopic Roux-en-Y Gastric Bypass: An Analysis of the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program Database.

Authors:  Colette S Inaba; Christina Y Koh; Sarath Sujatha-Bhaskar; Lishi Zhang; Ninh T Nguyen
Journal:  J Am Coll Surg       Date:  2018-02-08       Impact factor: 6.113

2.  Fast Track Program in Conversion Bariatric Surgery, as Safe as in Primary Bariatric Surgery?

Authors:  Abdelrahman Mohammad Galal; Evert-Jan Boerma; Sofie Fransen; Berry Meesters; Steven Olde Damink; Jan Willem Greve
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

3.  Factors Predicting Length of Stay Following Bariatric Surgery: Retrospective Review of a Single UK Tertiary Centre Experience.

Authors:  Fahad Mahmood; Alistair J Sharples; Adriana Rotundo; Nagammapudur Balaji; Vittal S R Rao
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

4.  Trends, Outcomes, and Impact of Early Discharge Following Bariatric Surgery: a Retrospective MBSAQIP Analysis of 748,955 Patients.

Authors:  Kieryn Houlder; Valentin Mocanu; Kevin Verhoeff; Gabriel Marcil; Daniel W Birch; Shahzeer Karmali; Noah J Switzer
Journal:  Obes Surg       Date:  2022-05-27       Impact factor: 3.479

5.  Preoperative Slow-Release Morphine Reduces Need of Postoperative Analgesics and Shortens Hospital Stay in Laparoscopic Gastric Bypass.

Authors:  Jakob Hedberg; Hanna Zacharias; Lars Janson; Magnus Sundbom
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

6.  Long-term Emergency Department Visits and Readmissions After Laparoscopic Roux-en-Y Gastric Bypass: a Systematic Review.

Authors:  N van Olst; A S van Rijswijk; S Mikdad; L J Schoonmade; A W van de Laar; Y I Z Acherman; S C Bruin; D L van der Peet; L M de Brauw
Journal:  Obes Surg       Date:  2021-04-04       Impact factor: 4.129

7.  Early discharge after lung resection is safe: 10-year experience.

Authors:  Christopher W Towe; Alina Khil; Vanessa P Ho; Yaron Perry; Luis Argote-Greene; Katherine M Wu; Philip A Linden
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.